Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex, Inc.

36.07
-0.1400-0.39%
Volume:231.10K
Turnover:8.36M
Market Cap:5.72B
PE:-127.23
High:36.52
Open:36.05
Low:35.81
Close:36.21
Loading ...

Scotiabank Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
21 May

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool
·
21 May

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
21 May

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool
·
20 May

Vertex Minerals Commences Gold Processing at Reward Gold Mine

TIPRANKS
·
20 May

Vertex Pharmaceuticals Authorizes $4 Billion In Additional Share Repurchases

Dow Jones
·
20 May

Vertex Pharmaceuticals Launches $4 Billion Stock Buyback

TIPRANKS
·
20 May

V2X Completes Public Offering of Common Stock

TIPRANKS
·
20 May

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Motley Fool
·
18 May

Venu Holding Corporation Accelerates Expansion with New Partnerships and Record-Setting Sales in Q1 2025

Reuters
·
17 May

Vertex Aerospace Launches Secondary Offering for 2 Million V2X Shares

MT Newswires Live
·
16 May

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
16 May

Vertex Resource Group Ltd. Reports Q1 2025 Financial Results Amid Global Trade Challenges

TIPRANKS
·
15 May

Press Release: Vertex Resource Group Ltd. Reports First Quarter 2025 Results

Dow Jones
·
15 May

Ryan J. Leib, Chief Accounting Officer, Reports Disposal of Vertex Inc. Common Shares

Reuters
·
15 May

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Motley Fool
·
14 May

Vertex Minerals Announces Quotation of New Securities on ASX

TIPRANKS
·
14 May

Vertex Minerals Issues New Shares Following Loan Conversion

TIPRANKS
·
14 May

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
14 May

2 Biotech Stocks That Are Screaming Buys in May

Motley Fool
·
13 May